Characteristics of tolerance in the guinea pig ileum produced by chronic in vivo exposure to opioid versus cannabinoid agonists

Biochemical Pharmacology

Volumn 80, Issue 4, 2010, Pages 522-532

  Maguma, Hercules ^a   Thayne, Kathleen ^a   Taylor, David A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Adaptation; Cannabinoid; Guinea pig; Longitudinal muscle myenteric plexus; Opioid; Tolerance

Indexed keywords

2 CHLOROADENOSINE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; MU OPIATE RECEPTOR; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG TOLERANCE; EVENING DOSAGE; FEMALE; GUINEA PIG; IC 50; ILEUM; IN VIVO STUDY; INHIBITION KINETICS; LONG TERM EXPOSURE; MALE; MORNING DOSAGE; MYENTERIC PLEXUS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY; SMOOTH MUSCLE CONTRACTION;

2-CHLOROADENOSINE; ADENOSINE; ANALGESICS, OPIOID; ANIMALS; BENZOXAZINES; CANNABINOIDS; DRUG INTERACTIONS; DRUG TOLERANCE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GUINEA PIGS; ILEUM; MORPHINE; MORPHOLINES; MUSCLE CONTRACTION; NAPHTHALENES; RECEPTORS, OPIOID, MU;

EID: 77953916456     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.05.005     Document Type: Article

References (51)

1. Bass C.E., Martin B.R. Time course for the induction and maintenance of tolerance to delta(9)-tetrahydrocannabinol in mice. Drug Alcohol Depend 2000, 60:113-119.
2. Alvarez V.A., Arttamangkul S., Dang V., Salem A., Whistler J.L., Von Zastrow M., et al. mu-Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization. J Neurosci 2002, 22:5769-5776.
3. Bailey C.P., Connor M. Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 2005, 5:60-68.
4. Martin B.R., Sim-Selley L.J., Selley D.E. Signaling pathways involved in the development of cannabinoid tolerance. Trends Pharmacol Sci 2004, 25:325-330.
5. Pertwee R.G., Stevenson L.A., Elrick D.B., Mechoulam R., Corbett A.D. Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br J Pharmacol 1992, 105:980-984.
6. Basilico L., Parolaro D., Colleoni M., Costa B., Giagnoni G. Cross-tolerance and convergent dependence between morphine and cannabimimetic agent WIN 55,212-2 in the guinea-pig ileum myenteric plexus. Eur J Pharmacol 1999, 376:265-271.
7. Guagnini F., Cogliati P., Mukenge S., Ferla G., Croci T. Tolerance to cannabinoid response on the myenteric plexus of guinea-pig ileum and human small intestinal strips. Br J Pharmacol 2006, 148:1165-1173.
8. Howlett A.C., Fleming R.M. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol 1984, 26:532-538.
9. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002, 54:161-202.
10. Rhim H., Miller R.J. Opioid receptors modulate diverse types of calcium channels in the nucleus tractus solitarius of the rat. J Neurosci 1994, 14:7608-7615.
11. Bouaboula M., Poinot-Chazel C., Bourrie B., Canat X., Calandra B., Rinaldi-Carmona M., et al. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 1995, 312(Pt 2):637-641.
12. McAllister S.D., Griffin G., Satin L.S., Abood M.E. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system. J Pharmacol Exp Ther 1999, 291:618-626.
13. Ross R.A., Brockie H.C., Fernando S.R., Saha B., Razdan R.K., Pertwee R.G. Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine. Br J Pharmacol 1998, 125:1345-1351.
14. Rawls S.M., Cabassa J., Geller E.B., Adler M.W. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)- 6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia. J Pharmacol Exp Ther 2002, 301:963-968.
15. Rosow C.E., Miller J.M., Pelikan E.W., Cochin J. Opiates and thermoregulation in mice. I. Agonists. J Pharmacol Exp Ther 1980, 213:273-283.
16. Salio C., Fischer J., Franzoni M.F., Mackie K., Kaneko T., Conrath M. CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn. Neuroreport 2001, 12:3689-3692.
17. Manzanares J., Corchero J., Romero J., Fernandez-Ruiz J.J., Ramos J.A., Fuentes J.A. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 1999, 20:287-294.
18. Lichtman A.H., Martin B.R. Cannabinoid tolerance and dependence. Handb Exp Pharmacol 2005, 691-717.
19. Nestler E.J. Cellular responses to chronic treatment with drugs of abuse. Crit Rev Neurobiol 1993, 7:23-39.
20. Rhee M.H., Nevo I., Avidor-Reiss T., Levy R., Vogel Z. Differential superactivation of adenylyl cyclase isozymes after chronic activation of the CB(1) cannabinoid receptor. Mol Pharmacol 2000, 57:746-752.
21. Gintzler A.R., Chakrabarti S. Post-opioid receptor adaptations to chronic morphine; altered functionality and associations of signaling molecules. Life Sci 2006, 79:717-722.
22. Meng J., Malanga C.J., Kong J.Q., Taylor D.A., Fleming W.W. Hyperpolarizing effects of morphine, clonidine and 2-chloroadenosine in myenteric neurons associated with tolerance to morphine. J Pharmacol Exp Ther 1997, 281:41-47.
23. Johnson S.M., Westfall D.P., Howard S.A., Fleming W.W. Sensitivities of the isolated ileal longitudinal smooth muscle-myenteric plexus and hypogastric nerve-vas deferens of the guinea pig after chronic morphine pellet implantation. J Pharmacol Exp Ther 1978, 204:54-66.
24. Taylor D.A., Leedham J.A., Doak N., Fleming W.W. Morphine tolerance and nonspecific subsensitivity of the longitudinal muscle myenteric plexus preparation of the guinea-pig to inhibitory agonists. Naunyn Schmiedebergs Arch Pharmacol 1988, 338:553-559.
25. Leedham J.A., Kong J.Q., Taylor D.A., Johnson S.M., Fleming W.W. Membrane potential in myenteric neurons associated with tolerance and dependence to morphine. J Pharmacol Exp Ther 1992, 263:15-19.
26. Schulz R., Goldstein A. Morphine tolerance and supersensitivity to 5-hydroxytryptamine in the myenteric plexus of the guinea-pig. Nature 1973, 244:168-170.
27. + ATPase alpha-subunit isoform distribution and abundance in guinea-pig longitudinal muscle/myenteric plexus after exposure to morphine. Brain Res 2002, 931:186-193.
28. Li P., Maguma H.T., Thayne K., Davis B., Taylor D.A. Correlation of the time course development and decay of tolerance to morphine wiht alterations in sodium pump protein isoform abundance. Biochem Pharmacol 2010, 79:1015-1024.
29. Taylor D.A., Fleming W.W. Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 2001, 297:11-18.
30. Johnson S.M., Fleming W.W. Mechanisms of cellular adaptive sensitivity changes: applications to opioid tolerance and dependence. Pharmacol Rev 1989, 41:435-488.
31. Rezvani A., Huidobro-Toro J.P., Hu J., Way E.L. A rapid and simple method for the quantitative determination of tolerance development to opiates in the guinea-pig ileum in vitro. J Pharmacol Exp Ther 1983, 225:251-255.
32. Coutts A.A., Pertwee R.G. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br J Pharmacol 1997, 121:1557-1566.
33. Kojima Y., Takahashi T., Fujina M., Owyang C. Inhibition of cholinergic transmission by opiates in ileal myenteric plexus is mediated by kappa receptor. Involvement of regulatory inhibitory G protein and calcium N-channels. J Pharmacol Exp Ther 1994, 268:965-970.
34. Sim-Selley L.J., Vogt L.J., Xiao R., Childers S.R., Selley D.E. Region-specific changes in 5-HT(1A) receptor-activated G-proteins in rat brain following chronic buspirone. Eur J Pharmacol 2000, 389:147-153.
35. Sim L.J., Selley D.E., Dworkin S.I., Childers S.R. Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain. J Neurosci 1996, 16:2684-2692.
36. Johnson E.A., Oldfield S., Braksator E., Gonzalez-Cuello A., Couch D., Hall K.J., et al. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells. Mol Pharmacol 2006, 70:676-685.
37. Mizutani A., Arvidsson J., Chahl L.A. Sensitization to morphine withdrawal in guinea-pigs. Eur J Pharmacol 2005, 509:135-143.
38. Spina E., Trovati A., Parolaro D., Giagnoni G. A role of nitric oxide in WIN 55,212-2 tolerance in mice. Eur J Pharmacol 1998, 343:157-163.
39. Stephenson R.P. A modification of receptor theory. Br J Pharmacol Chemother 1956, 11:379-393.
40. Chavkin C., Goldstein A. Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus. Proc Natl Acad Sci USA 1984, 81:7253-7257.
41. Kong J.Q., Leedham J.A., Taylor D.A., Fleming W.W. Evidence that tolerance and dependence of guinea pig myenteric neurons to opioids is a function of altered electrogenic sodium-potassium pumping. J Pharmacol Exp Ther 1997, 280:593-599.
42. Gonzalez S., Cebeira M., Fernandez-Ruiz J. Cannabinoid tolerance and dependence: a review of studies in laboratory animals. Pharmacol Biochem Behav 2005, 81:300-318.
43. Hojo M., Sudo Y., Ando Y., Minami K., Takada M., Matsubara T., et al. mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis. J Pharmacol Sci 2008, 108:308-319.
44. Pfeiffer M., Kirscht S., Stumm R., Koch T., Wu D., Laugsch M., et al. Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. J Biol Chem 2003, 278:51630-51637.
45. Coutts A.A., Irving A.J., Mackie K., Pertwee R.G., Anavi-Goffer S. Localisation of cannabinoid CB(1) receptor immunoreactivity in the guinea pig and rat myenteric plexus. J Comp Neurol 2002, 448:410-422.
46. Ho A., Lievore A., Patierno S., Kohlmeier S.E., Tonini M., Sternini C. Neurochemically distinct classes of myenteric neurons express the mu-opioid receptor in the guinea pig ileum. J Comp Neurol 2003, 458:404-411.
47. Thorat S.N., Bhargava H.N. Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice. Eur J Pharmacol 1994, 260:5-13.
48. Smith P.B., Welch S.P., Martin B.R. Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice. J Pharmacol Exp Ther 1994, 268:1381-1387.
49. Hine B. Morphine and delta 9-tetrahydrocannabinol: two-way cross tolerance for antinociceptive and heart-rate responses in the rat. Psychopharmacology (Berl) 1985, 87:34-38.
50. Shapira M., Gafni M., Sarne Y. Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulation. Brain Res 2003, 960:190-200.
51. Bloom A.S., Dewey W.L. A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse. Psychopharmacology (Berl) 1978, 57:243-248.